Xenon Pharmaceuticals Inc.

XENE | NASDAQ

Price Alert Chart Builder DCF Calculator

$38.72

-$0.27 (-0.69%)

Sep 22, 2026, 1:20 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-345.91M	-234.33M	-182.39M	-125.37M	-78.88M	-28.84M
Depreciation & Amortization	2.54M	2.56M	3.54M	1.62M	906K	644K
Stock-Based Compensation	53.71M	50.72M	32.37M	20.38M	10.02M	5.68M
Other Working Capital	-1.26M	-2.2M	1.57M	-10.5M	-2.19M	-25.06M
Other Non-Cash Items	9.38M	2.82M	-4.19M	5.66M	1.05M	766K
Deferred Income Tax	-3.2M	-8.86M	-292K	-44K	58K	-285K
Change in Working Capital	4.36M	5.71M	5.64M	-676K	-2.65M	-26.09M
Operating Cash Flow	-279.12M	-181.39M	-145.33M	-98.43M	-69.5M	-48.12M
Capital Expenditures	-799K	-3.08M	-5.62M	-2.89M	-2.05M	-2.64M
Cash Acquisitions	n/a	n/a	n/a	296M	-144.75M	-214.71M
Purchase of Investments	-355.66M	-532.27M	-793.91M	-551.14M	-389.47M	-228.9M
Sales Maturities Of Investments	574.45M	700.34M	682.35M	258.03M	144.75M	214.71M
Other Investing Acitivies	n/a	n/a	n/a	-296M	144.75M	214.71M
Investing Cash Flow	218M	165M	-117.17M	-296M	-246.77M	-16.82M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	-16.74M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	47K	35K	705K	260K	82K
Financial Cash Flow	117.11M	12.13M	353.52M	278.47M	447.54M	85.8M
Net Cash Flow	56.45M	-5.93M	91.4M	-118.45M	130.68M	20.25M
Free Cash Flow	-279.92M	-184.46M	-150.94M	-101.32M	-71.55M	-50.76M
Adj. Free Cash Flow	-333.62M	-235.18M	-183.32M	-121.7M	-81.57M	-56.44M
Maintenance CapEx	n/a	-3.08M	-5.62M	-2.89M	-2.05M	n/a
Growth CapEx	-799K	n/a	n/a	n/a	n/a	-2.64M
Owner Earnings	-279.12M	-184.46M	-150.94M	-101.32M	-71.55M	-48.12M